[HTML][HTML] Barriers and enablers of healthcare providers to deprescribe cardiometabolic medication in older patients: a focus group study

J Abou, S Crutzen, V Tromp, M Heringa, R Van Marum… - Drugs & Aging, 2022 - Springer
Introduction Benefits and risks of preventive medication change over time for ageing patients
and deprescribing of medication may be needed. Deprescribing of cardiovascular and …

[HTML][HTML] Barriers and enablers of older patients to deprescribing of cardiometabolic medication: a focus group study

…, JG Hugtenburg, ML Bouvy, M Heringa… - Frontiers in …, 2020 - frontiersin.org
Background Deprescribing has been recommended for managing polypharmacy but
deprescribing preventive medication in older patients is still uncommon. We aimed to investigate …

[HTML][HTML] Older people's attitudes towards deprescribing cardiometabolic medication

…, J Abou, SE Smits, G Baas, JG Hugtenburg, M Heringa… - BMC geriatrics, 2021 - Springer
Background Overtreatment with cardiometabolic medication in older patients can lead to
major adverse events. Timely deprescribing of these medications is therefore essential. Self-…

Predictors for inappropriate proton pump inhibitor use: observational study in primary care

…, JS Frankema, EJ Heeregrave, M Heringa… - British Journal of …, 2022 - bjgp.org
Background Proton pump inhibitor (PPI) indications are limited to gastrointestinal disorders
and ulcer prophylaxis. However, PPIs are among the most frequently prescribed drugs. Aim …

Reducing inappropriate drug use in older patients by use of clinical decision support in community pharmacy: a mixed-methods evaluation

LGM Mulder-Wildemors, M Heringa… - Drugs & Aging, 2020 - Springer
Introduction Older people are prone to drug-related harm. Clinical decision support systems
(CDSSs) in community pharmacies may improve appropriate prescribing in this population. …

[HTML][HTML] Facilitating pharmacy staff's conversations about non-medical medication switches: Development and testing of a communication training

L Schackmann, M Heringa, M Wolters, A Faber… - Research in Social and …, 2023 - Elsevier
Background Non-medical medication switches, a change to another medicine or medication
label not motivated by medical reasons, occur frequently. Switches often lead to negative …

Better specification of triggers to reduce the number of drug interaction alerts in primary care

M Heringa, A van der Heide… - International Journal of …, 2018 - Elsevier
Objective Drug interaction alerts (drug–drug and drug-disease interaction alerts) for chronic
medications substantially contribute to alert fatigue in primary care. The aim of this study was …

[HTML][HTML] The CombiConsultation for patients with diabetes, COPD and cardiovascular diseases: Evaluation of interventions and personal health-related goals

VAM Meijvis, M Heringa, HF Kwint, NJ de Wit… - Research in Social and …, 2023 - Elsevier
Background The CombiConsultation is a consultation with the community pharmacist for
patients with diabetes, COPD and/or cardiovascular disease (CVD), aligned with the annual or …

Pharmacist-led intervention aimed at deprescribing and appropriate use of cardiometabolic medication among people with type 2 diabetes

S Crutzen, G Baas, P Denig, M Heringa… - Research in Social and …, 2023 - Elsevier
Background Potential overtreatment with cardiometabolic medication (ie, glucose lowering
medication, antihypertensives and statins) has been observed in 10–40% of older people …

Nature and frequency of drug therapy alerts generated by clinical decision support in community pharmacy

M Heringa, A Floor‐Schreudering… - … and Drug Safety, 2016 - Wiley Online Library
Purpose The purpose of this study is to investigate the nature, frequency, and determinants
of drug therapy alerts generated by a clinical decision support system (CDSS) in community …